XML 72 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2021
Mar. 31, 2021
Mar. 31, 2020
Current assets:      
Cash and cash equivalents $ 1,996,733 $ 2,055,044 $ 2,183,207
Restricted cash 2,711 77,701 2,275
Other current assets 58,165 54,250 33,763
Total current assets 2,057,609 2,186,995 2,219,245
Property and equipment, net 15,550 14,749 8,962
Operating lease right-of-use assets 65,163 62,279 64,970
Restricted cash, net of current portion 8,933 8,931 83,770
Investments measured at fair value 180,359 188,978 93,445
Long-term investment 100,563 100,563 0
Other assets 26,520 27,197 6,659
Total assets 2,454,697 2,589,692 2,477,051
Current liabilities:      
Accounts payable 15,014 20,550 10,306
Accrued expenses 73,788 76,936 68,621
Operating lease liabilities 12,055 12,313 7,839
Deferred consideration liability 100,000 100,000 0
Other current liabilities 8,301 9,162 5,352
Total current liabilities 209,158 218,961 92,118
Liability instruments measured at fair value 5,906 67,893 102,373
Operating lease liabilities, noncurrent 65,263 62,384 64,452
Long-term debt 186,350 170,280 108,592
Other liabilities 8,188 8,169 821
Total liabilities 474,865 527,687 368,356
Commitments and Contingencies  
Redeemable noncontrolling interest 22,491 22,491 22,491
Shareholders' equity:      
Common shares 0 0 0
Additional paid-in capital 3,824,974 3,814,805 3,143,739
Subscription receivable (100,000) (100,000) 0
Accumulated deficit (2,000,645) (1,918,462) (1,109,228)
Accumulated other comprehensive (loss) income (1,207) 1,445 (2,349)
Shareholders' equity attributable to Roivant Sciences Ltd. 1,723,122 1,797,788 2,032,162
Noncontrolling interests 234,219 241,726 54,042
Total shareholders' equity 1,957,341 2,039,514 2,086,204
Total liabilities, redeemable noncontrolling interest and shareholders' equity $ 2,454,697 $ 2,589,692 $ 2,477,051